Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene therapy: lessons learned from liver transplantation for transthyretin-amyloidosis.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Dec 2004

Suhr Ole B, Holmgren Gösta, Lundgren Erik

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial
Share to Genetic Therapy
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Transplantation

Share to Prealbumin

Source

Identifiers

PMID: 15558840
DOI: 10.1002/lt.20302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene therapy: lessons learned from liver transplantation for transthyretin-amyloidosis.PMID 15558840Read ↗

RNA-targeting and gene editing therapies for transthyretin amyloidosisSemantic proximity Read ↗

Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter FutureSemantic proximity Read ↗

Transthyretin Amyloid Cardiomyopathy Treatment: An Updated ReviewSemantic proximity Read ↗

The transthyretin amyloidoses: advances in therapySemantic proximity Read ↗

Gene therapy for liver diseases — progress and challengesSemantic proximity Read ↗

[Transthyretin-related hereditary amyloidosis].Semantic proximity Read ↗

Treating hereditary transthyretin amyloidosis: Present & future challenges.Semantic proximity Read ↗

Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathySemantic proximity Read ↗

mRNA and gene editing: Late breaking therapies in liver diseasesSemantic proximity Read ↗

Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatmentsSemantic proximity Read ↗

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisSemantic proximity Read ↗

Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.